ArticleThe oncologist2025

Benefit of adjuvant chemotherapy for T1cN0M0 and selected T1bN0M0 triple-negative breast cancer: a nationwide cancer registry-based study.

Chiao Lo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.